Instem plc Notice of Results (6276D)
24 February 2020 - 6:00PM
UK Regulatory
TIDMINS
RNS Number : 6276D
Instem plc
24 February 2020
Instem plc
("Instem" or the "Company")
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the
global life sciences market, will announce results for the year
ended 31 December 2019 on Monday 30 March 2020.
Analyst Presentation
Management will be hosting a presentation on the day of the
results at 10.30am at the offices of Walbrook PR, 4 Lombard Street,
London, EC3V 9HD. Analysts wishing to attend the presentation
should register their interest by emailing instem@walbrookpr.com or
by telephoning 020 7933 8780.
For further information, please contact:
Instem plc via Walbrook PR
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser
& Broker) +44 (0) 20 7496 3000
Peter Steel
Rachel Hayes
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
Nicholas Johnson
About Instem
Instem is a leading provider of IT solutions & services to
the life sciences market delivering compelling solutions for Study
Management and Data Collection; Regulatory Solutions for
Submissions and Compliance; and Informatics-based Insight
Generation.
Instem solutions are in use by over 500 customers worldwide,
including all the largest 25 pharmaceutical companies, enabling
clients to bring life enhancing products to market faster. Instem's
portfolio of software solutions increases client productivity by
automating study-related processes while offering the unique
ability to generate new knowledge through the extraction and
harmonisation of actionable scientific information.
Instem products and services now address aspects of the entire
drug development value chain, from discovery through to market
launch. Management estimate that over 50% of all drugs on the
market have been through some part of Instem's platform at some
stage of their development.
To learn more about Instem solutions and its mission, please
visit www.instem.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORZZGZZMGNGGZM
(END) Dow Jones Newswires
February 24, 2020 02:00 ET (07:00 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024